U.S. Health Care REITs Stock News

Yiren Digital (YRD) is back in focus after Q4 2025 results showed revenue of CN¥957.63 million, a net loss of CN¥882.16 million, and a temporary suspension of its cash dividend for the second half of 2025. See our latest analysis for Yiren Digital. The earnings miss and dividend suspension appear to have weighed heavily on sentiment, with a 7 day share price return of 44.19% and a 1 year total shareholder return of 69.72%. The 3 year total shareholder return remains slightly positive, which...

HeartFlow (NasdaqGS:HTFL) reported landmark real world data at ACC 2026 showing its AI Plaque Analysis as a leading independent predictor for cardiovascular risk stratification. The Plaque Analysis data is linked with improved patient outcomes and substantial cost savings in coronary artery disease management. The company launched the large scale NAVIGATE PCI Registry to study its AI driven PCI Navigator tool ahead of commercial release. HeartFlow’s AI platform is now backed by FDA cleared...

JinkoSolar Holding (NYSE:JKS) has entered a multi year supply agreement with Nextpower for U.S. manufactured steel module frames. The partnership centers on steel frames and deeper localization of JinkoSolar's U.S. solar module supply chain. The agreement supports JinkoSolar's efforts to source key components domestically and align with U.S. solar infrastructure priorities. For investors tracking NYSE:JKS, this move comes with the stock at around $23.4 and a mixed performance profile...

ArcBest's board is urging shareholders to vote against a climate related proposal ahead of the upcoming annual meeting. The proposal calls for the company to set greenhouse gas emission reduction targets. The board's stance highlights tension between management and some shareholders over environmental priorities and disclosure. ArcBest (NasdaqGS:ARCB) enters this vote with a current share price of $87.58 and a mixed recent return profile. The stock is up 3.2% over the past week and 13.5%...

Firefly Aerospace (FLY) just closed FY 2025 with fourth quarter revenue of US$57.7 million and a basic EPS loss of US$0.26, alongside trailing twelve month revenue of US$159.9 million and a TTM EPS loss of US$4.83, versus very large revenue growth of 163% over the past year. Over recent quarters, the company has seen revenue move from US$9.0 million in Q4 2024 to US$57.7 million in Q4 2025 while quarterly basic EPS losses shifted from US$7.86 to US$0.26. This leaves investors weighing robust...

If you are wondering whether Andersen Group at US$27.90 is offering fair value or an opportunity, the next sections will walk through what the current price really reflects. The stock has posted returns of 22.2% over the last 7 days, 24.6% over the last 30 days and 14.4% year to date, which has likely caught the eye of investors watching for changing risk and return profiles. Recent coverage has focused on Andersen Group's share price moves and how investors are reassessing the company, with...

BrightSpring Health Services (NasdaqGS:BTSG) is reallocating capital toward acquisitions and organic growth in its core home and clinical services. The company is accelerating de-leveraging efforts to increase financial flexibility. BrightSpring plans to divest its community-living operations, with the transaction expected to close soon. BrightSpring operates in home and clinical care, an area that sits at the intersection of aging demographics, pressure on institutional care settings, and...

Boone Capital Management has disclosed a significant new position in Tyra Biosciences. The investment comes as Tyra Biosciences advances multiple clinical trials centered on FGFR3 biology. The move highlights fresh institutional interest in NasdaqGS:TYRA at a current share price of $37.15. For readers tracking Tyra Biosciences, the company now sits at a share price of $37.15 with substantial recent share price momentum, including a 26.4% return over the past 30 days and 38.7% year to date...

Intellicheck (IDN) has rounded out FY 2025 with fourth quarter revenue of about US$6.6 million and basic EPS of roughly US$0.08, alongside trailing twelve month revenue of US$22.7 million and EPS of about US$0.07 that reflect a move into positive net income of around US$1.3 million over the year. The company has seen quarterly revenue progress from US$4.9 million in Q1 2025 to US$6.6 million in Q4 2025, with EPS shifting from a small loss of roughly US$0.02 per share early in the year to a...

If you are wondering whether GPGI is attractively priced or already reflecting a lot of optimism, the current share price at US$17.06 raises some useful questions about what you are really paying for. Recent returns are mixed, with the stock up 3.3% over the last week but showing a 27.4% decline over 30 days, an 8.6% decline year to date, and gains of 51.0% over 1 year, 191.8% over 3 years, and 114.8% over 5 years. These moves sit against a backdrop of ongoing coverage that keeps GPGI on...

FDA grants premarket approval to LivaNova's aura6000 System for adult patients with moderate to severe Obstructive Sleep Apnea who do not benefit from standard therapies. The system uses proximal hypoglossal nerve stimulation and is supported by clinical trial data showing meaningful outcomes, including in harder to treat patient groups. LivaNova (NasdaqGS:LIVN) also discloses work on a next generation, MRI compatible version of the aura6000 with additional features. LivaNova, listed on...

Entergy highlighted its support for workforce development and community resilience at the Dress for Success New Orleans event. Company leaders and employees participated in the event, underscoring involvement in local career readiness efforts. For investors watching Entergy (NYSE:ETR), this kind of community engagement sits alongside a share price of $99.9 and a value score of 3. The stock has seen a 6.4% return year to date and a 22.4% return over the past year, which gives added context...

Axcelis Technologies (NasdaqGS: ACLS) will serve as the Diamond Sponsor of the Compound Semiconductor Asia Conference (CS Asia) 2026 during SEMICON China. The company plans to launch its next generation Purion Power Series+ Platform for chipmakers in China at the event. Axcelis CEO Mary Puma is scheduled to deliver a keynote address to industry participants and customers. Axcelis Technologies focuses on ion implantation and related processing equipment for the semiconductor sector, with...

Global Ship Lease (NYSE:GSL) files a new US$229 million Shelf Registration. The company also publishes its 2025 Annual Report, covering recent fleet acquisitions and charter activity. Both filings offer fresh detail on capital plans, fleet growth, and charter coverage for the year ahead. Global Ship Lease focuses on owning and chartering containerships, so its funding plans and fleet moves matter directly for earnings power and balance sheet risk. The new US$229 million Shelf Registration...

Belpointe PREP (OZ) just reported its FY 2025 numbers with Q4 total revenue of about US$3.1 million and a basic EPS loss of US$2.96, set against a trailing twelve month loss of US$10.17 per share on revenue of roughly US$9.2 million. Over the last six quarters, total revenue has moved from about US$0.86 million in Q3 2024 to US$3.06 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$1.85 per share to a loss of US$3.12. This leaves investors focused on how much of that...

Wondering whether Marqeta at around US$4.08 is a bargain or a value trap right now? This article breaks down what the current price actually reflects. The stock has moved 2.8% over the past week, is flat over 30 days, and is showing a 12.1% decline year to date with a 7.7% decline over the last year but a 14.3% gain across three years. This gives mixed signals about how the market is treating the story. Recent company updates and product announcements in the payments space have kept Marqeta...

Canadian Solar (CSIQ) has capped FY 2025 with fourth quarter revenue of US$1.2 billion and a basic EPS loss of US$1.28, as net income excluding extra items came in at a loss of US$86.3 million, putting the spotlight firmly on profitability rather than top line scale. Over recent quarters, the company has seen revenue move between US$1.2 billion and US$1.7 billion, with basic EPS swinging from a profit of US$0.51 in Q4 2024 to a loss in Q4 2025. This sets up a results season where margin...

Alumis (ALMS) has just wrapped up FY 2025 with Q4 revenue of US$1.9 million, a basic EPS loss of US$0.89 per share, and a net loss of US$92.9 million. On a trailing twelve month basis, revenue was US$24.1 million, with a basic EPS loss of US$2.86 per share and a net loss of US$243.3 million. Over recent quarters, revenue moved from US$17.4 million in Q1 2025 to US$2.7 million in Q2, US$2.1 million in Q3, and US$1.9 million in Q4. EPS shifted from a loss of US$1.82 in Q1 to a profit of US$0.78...

Fortune Brands Innovations (NYSE:FBIN) has appointed an interim CEO and an interim CFO while launching a formal search for a permanent chief executive. The company reached a governance cooperation agreement with activist investor Ed Garden, who has joined the board of directors. The board plans to phase out its classified structure, following internal leadership changes and shareholder pressure that appear aimed at avoiding a proxy fight. For investors watching NYSE:FBIN, these leadership...

Gold Royalty (NYSEAM:GROY) recently reported three consecutive quarters of positive free cash flow, which management has described as a financial inflection point. The company reported record annual revenue and cash flow, alongside a shift to a zero-debt capital structure after equitizing debt and completing a major equity raise. Gold Royalty expanded its portfolio with a new royalty on BHP's Pedra Branca mine, adding exposure to an operating asset. Gold Royalty, which last closed at $3.15,...

Datavault AI (DVLT) closed out FY 2025 with fourth quarter revenue of US$33.8 million and basic EPS of roughly US$0.00, while trailing twelve month revenue stood at US$39.1 million and basic EPS reflected a loss of US$0.52. Over recent quarters, the company has seen revenue move from US$0.9 million in Q4 2024 to US$33.8 million in Q4 2025, as quarterly EPS shifted from a loss of US$2.00 to around breakeven. This sets up a results season where rapid top line expansion sits alongside still...

Ormat Technologies (NYSE:ORA) has priced $875 million of convertible senior notes in a significantly upsized offering. The company plans to use the proceeds to repurchase existing debt and shares, reshaping its capital structure. The transaction introduces new convertible securities that can affect future dilution and interest costs for shareholders. For readers tracking NYSE:ORA, this financing move comes with the stock at $110.52 and a 1 year return of 54.2%. Over 3 and 5 years, returns...

Edwards Lifesciences (NYSE:EW) has appointed Niranjan Pai as Director, Government Affairs. The new appointment places an experienced policy professional in a role focused on public policy and regulatory engagement. For investors tracking Edwards Lifesciences at a share price of $82.46, this move adds another piece to the broader picture around NYSE:EW. The company’s 1 year return of 16.2% sits alongside more modest 3 year and 5 year returns of 3.7% and 2.4%, which may prompt readers to pay...

Village Farms International reported fourth-quarter 2025 sales of US$49.62 million and net income of US$2.43 million, alongside full-year 2025 sales of US$215.94 million and net income of US$32.44 million, marking a shift from losses a year earlier. Over the same period, the company completed a repurchase of 812,923 shares for US$2.98 million, which, combined with the earnings turnaround, highlights management’s emphasis on improving profitability while also returning capital to...